TrialJAMA oncology2018

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.

Chiara Cremolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.